Log in to save to my catalogue

Efficacy Results of a Trial of a Herpes Simplex Vaccine

Efficacy Results of a Trial of a Herpes Simplex Vaccine

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3287348

Efficacy Results of a Trial of a Herpes Simplex Vaccine

About this item

Full title

Efficacy Results of a Trial of a Herpes Simplex Vaccine

Publisher

Waltham, MA: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2012-01, Vol.366 (1), p.34-43

Language

English

Formats

Publication information

Publisher

Waltham, MA: Massachusetts Medical Society

More information

Scope and Contents

Contents

There is no vaccine to prevent herpes simplex virus (HSV) infection. In this trial in 8323 women, a candidate HSV vaccine containing glycoprotein D was found to be ineffective in preventing HSV-2 infection.
Both herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) can cause primary infection of the genital tract, and HSV-1 infection has become...

Alternative Titles

Full title

Efficacy Results of a Trial of a Herpes Simplex Vaccine

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3287348

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3287348

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1103151

How to access this item